Evidence map›Paper›PMID 29619192›Full record

ArticleChemical science2017

Synthesis of poly(1,2-glycerol carbonate)-paclitaxel conjugates and their utility as a single high-dose replacement for multi-dose treatment regimens in peritoneal cancer.

Iriny Ekladious, Rong Liu, Heng Zhang, Daniel H Foil, Daniel A Todd, Tyler N Graf, Robert F Padera, Nicholas H Oberlies, Yolonda L Colson, Mark W Grinstaff

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 31 citations in OpenAlex.

  1. Novel Hydroxyl-Functional Aliphatic COInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. High dose, dual-release polymeric films for extended surgical bed paclitaxel delivery.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  7. Article
  8. Article
  9. Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications.Angewandte Chemie (International ed. in English) · 2022
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Iriny EkladiousDepartments of Biomedical Engineering and Chemistry , Boston University , Boston , MA 02215 , USA . Email: mgrin@bu.edu.ORCID 0000-0003-1192-1414
Rong LiuDepartment of Surgery , Brigham and Women's Hospital , Boston , MA 02215 , USA . Email: ycolson@bwh.harvard.edu.ORCID 0000-0001-5876-1986
Heng ZhangDepartments of Biomedical Engineering and Chemistry , Boston University , Boston , MA 02215 , USA . Email: mgrin@bu.edu.ORCID 0000-0002-7475-4185
Daniel H FoilDepartment of Chemistry and Biochemistry , University of North Carolina at Greensboro , Greensboro , NC 27402 , USA.ORCID 0000-0003-0512-8997
Daniel A ToddDepartment of Chemistry and Biochemistry , University of North Carolina at Greensboro , Greensboro , NC 27402 , USA.ORCID 0000-0003-2199-1029
Tyler N GrafDepartment of Chemistry and Biochemistry , University of North Carolina at Greensboro , Greensboro , NC 27402 , USA.ORCID 0000-0003-4145-2815
Robert F PaderaDepartment of Pathology , Brigham and Women's Hospital , Boston , MA 02215 , USA.ORCID 0000-0002-4571-5494
Nicholas H OberliesDepartment of Chemistry and Biochemistry , University of North Carolina at Greensboro , Greensboro , NC 27402 , USA.ORCID 0000-0002-0354-8464
Yolonda L ColsonDepartment of Surgery , Brigham and Women's Hospital , Boston , MA 02215 , USA . Email: ycolson@bwh.harvard.edu.ORCID 0000-0002-8229-5636
Mark W GrinstaffDepartments of Biomedical Engineering and Chemistry , Boston University , Boston , MA 02215 , USA . Email: mgrin@bu.edu.ORCID 0000-0002-5453-3668
University of North Carolina at Greensboro · USBoston University · USBrigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current chemotherapeutic dosing strategies are limited by the toxicity of anticancer agents and therefore rely on multiple low-dose administrations. As an alternative, we describe a novel sustained-release, biodegradable polymeric nanocarrier as a single administration replacement of multi-dose paclitaxel (PTX) treatment regimens. The first synthesis of poly(1,2-glycerol carbonate)-

Identifiers

PMID29619192
PMCPMC5863611
OpenAlexW2765920141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.